CORTICOSTEROID-FREE REMISSION OF ULCERATIVE COLITIS WITH FILGOTINIB MAINTENANCE THERAPY: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY

Edward V Loftus Jr  ¹     Severine Vermeire  ²     Chohee Yun  ³     Jeremy Hsieh  ³     Xiaopeng Liu  ³     Sally Zhao  ³     Ulrik Moerch  ⁴     Toshifumi Hibi  ⁵     Brian G. Feagan  ⁶     William Sandborn  ^7    
1 Mayo Clinic College of Medicine, Rochester, MN, United States
² University Hospitals Leuven, Leuven, Belgium
³ Gilead Sciences, Inc., Foster City, CA, United States
⁴ Gilead Sciences, Inc., Copenhagen, Denmark
⁵ Kitasato Institute Hospital, Kitasato University, Tokyo, Japan
⁶ Western University, London, ON, Canada
⁷ University of California, San Diego, La Jolla, CA, United States

Topic
IBD

Session
IBD: Clinical trials II (small molecules)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)